Skip to main content
. 2019 Nov 21;11(12):1840. doi: 10.3390/cancers11121840

Figure 1.

Figure 1

Kaplan–Meier plots of overall- (OS) and disease-specific (DSS) survival associated with anilin actin binding protein (ANLN) and transducing-like enhancer protein 2 (TLE2) risk stratification in the Mannheim cohort. The group with high ANLN expression showed worse OS (a) and DSS (b) than the group with low expression. The group with high TLE2 expression displayed more favorable OS (c) and DSS (d) than the group with low expression.